Toward the development of chemoprevention agents. Part II: Chemo-enzymatic synthesis and anti-inflammatory activities of a new class of 5-amino-2-substitutedphenyl-1,3-dioxacycloalkanes
被引:21
作者:
Gu, Keli
论文数: 0引用数: 0
h-index: 0
机构:Capital Med Univ, Coll Pharmaceut Sci, Beijing 100054, Peoples R China
Gu, Keli
Bi, Lanrong
论文数: 0引用数: 0
h-index: 0
机构:Capital Med Univ, Coll Pharmaceut Sci, Beijing 100054, Peoples R China
Bi, Lanrong
Zhao, Ming
论文数: 0引用数: 0
h-index: 0
机构:
Capital Med Univ, Coll Pharmaceut Sci, Beijing 100054, Peoples R ChinaCapital Med Univ, Coll Pharmaceut Sci, Beijing 100054, Peoples R China
Zhao, Ming
[1
]
Wang, Chao
论文数: 0引用数: 0
h-index: 0
机构:Capital Med Univ, Coll Pharmaceut Sci, Beijing 100054, Peoples R China
Wang, Chao
Ju, Jingfang
论文数: 0引用数: 0
h-index: 0
机构:Capital Med Univ, Coll Pharmaceut Sci, Beijing 100054, Peoples R China
Ju, Jingfang
Peng, Shiqi
论文数: 0引用数: 0
h-index: 0
机构:Capital Med Univ, Coll Pharmaceut Sci, Beijing 100054, Peoples R China
Peng, Shiqi
机构:
[1] Capital Med Univ, Coll Pharmaceut Sci, Beijing 100054, Peoples R China
[2] Peking Univ, Coll Pharmaceut Sci, Beijing 100083, Peoples R China
[3] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA
A new series of optically pure 5-amino-2-substitutedphenyl-1,3-dioxacyclozilkanes were designed and synthesized via a chemo-enzymatic combined method to develop new chemoprevention agents. Twenty-four of newly synthesized compounds significantly inhibited xylene-induced rat ear edema and exhibited comparable or better anti-inflammatory activities than the reference drug aspirin. Treatment of these anti-inflammatory agents did not prolong the tail bleeding time in rat. In addition, 5-amino-2-substitutedphenyl- I 3-dioxacycloalkanes exhibited good membrane permeability based on in vitro Caco-2 cell monolayer permeability assay. Furthermore, some preliminary structure-activity relationships were further analyzed among these compounds. Taken together, 5-amino-2-substitutedphenyl-1,3-dioxacycloalkanes may represent a new class of anti-inflammatory drugs with safer pharmacological profile. (c) 2007 Elsevier Ltd. All rights reserved.